Audrey Lew

Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada.

CML Global Capital Ltd. provides commercial real estate services. It focuses on management and development of real estate properties, real estate ownership, and parking management in North America and Southeast Asia. The company was founded on October 29, 1985 and is located in Calgary, Canada.

Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada.

CML Global Capital Ltd. provides commercial real estate services. It focuses on management and development of real estate properties, real estate ownership, and parking management in North America and Southeast Asia. The company was founded on October 29, 1985 and is located in Calgary, Canada.

CML Global Capital Ltd. provides commercial real estate services. It focuses on management and development of real estate properties, real estate ownership, and parking management in North America and Southeast Asia. The company was founded on October 29, 1985 and is located in Calgary, Canada.

CML Global Capital Ltd. provides commercial real estate services. It focuses on management and development of real estate properties, real estate ownership, and parking management in North America and Southeast Asia. The company was founded on October 29, 1985 and is located in Calgary, Canada.